Zomedica Stock News

Investors who bought the rumor now appear to be selling the news.

Zomedica's product launch will push its value higher. ZOM stock is worth between $2.45 to $3.17 with a 10% share of the pet diagnostic lab market.

There are a few things you should know before risking your hard-earned money on this stock.

Reddit penny stocks continue to be of interest to risky investors and InvestorPlace is looking at the top ones for Monday. The post 10 Reddit Penny Stocks Seeing the Most Chatter Today appeared first

ZOM stock is simply too good of an opportunity to pass by. Veterinary diagnostics is a growing sector, and ZOM revenues are just beginning.

Zomedica launched its Truforma point-of-care diagnostic platform March 16, ahead of schedule. That's excellent news if you own ZOM stock.

More stimulus means more money flowing into the stock market. Here are seven meme stocks that may benefit from the government's largesse.

Investors in ZOM stock have been well-rewarded of late, as the company announced its first commercial sale of its flagship product. The post Zomedica Soars After Commercial Launch, but It's Not Sustai

Zomedica is launching a product that will bring revenue through the door. But with a small addressable market, ZOM stock may not have much upside.

Retail investors over on Reddit Penny Stocks are showing interest in quite a few interesting players today that investors will want to note. The post 7 Reddit Penny Stocks Seeing the Most Chatter Toda

The stock price of Zomedica Corp (NYSEAMERICAN: ZOM) has increased by over 10% pre-market. This is why it happened.

ANN ARBOR, Mich., March 16, 2021 (GLOBE NEWSWIRE) -- Zomedica Corp. (NYSE American: ZOM) (“Zomedica” or the “Company”), a veterinary health company creating point-of-care diagnostics products

They're off to a good start.

The jury may still be out on their future price movements, but these seven Reddit stocks, trading at penny stock levels, remain popular plays among the WSB community. The post 7 Penny Stocks Flying Hi

Analysts and economists are expecting the U.S. economy to significantly accelerate in coming quarters as the coronavirus vaccine rollout facilitates the reopening of many businesses and the unlocking